Objective: To describe the efficacy of treatment for tegumentary leishmaniasis in Brazil, its CE and alternative treatments. Methods: This is a qualitative, retrospective and cross-sectional study carried out through an integrative literature review. The regional portal of the Virtual Health Library (VHL) and the National Library of Medicine of the United States (PubMed) were used. Articles published in the last 10 years (2014-2024); Controlled clinical trial type, free and full text. After reading the articles and using the criteria, a total of 20 articles were maintained. Results: It was observed that in Brazil they are used for the first line of treatment for TL, which are high-cost drugs that present limitations in patient management due to toxicity, need for parenteral administration and hospitalization. New treatment alternatives, such as miltefosine, pentoxifylline, liposomal amphotericin B, thermotherapy, and tamoxifen, have been used with similar cure rates and lower CE and could be recommended as a treatment option. Conclusion: The CE of the treatments interfere with the follow-up of the therapy, and it is necessary to use new drugs to bring comfort to the patients, increase efficacy and adherence.
Read full abstract